Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126474271 | 12647427 | 1 | I | 20160704 | 20160729 | 20160812 | 20160812 | EXP | TR-TAKEDA-2016MPI007136 | TAKEDA | 46.00 | YR | M | Y | 55.00000 | KG | 20160812 | MD | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126474271 | 12647427 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 21602 | INJECTION | |||||||||
| 126474271 | 12647427 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 21602 | INJECTION | |||||||||
| 126474271 | 12647427 | 3 | SS | Lenalidomide | LENALIDOMIDE | 1 | Oral | UNK | 0 | ||||||||||
| 126474271 | 12647427 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126474271 | 12647427 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126474271 | 12647427 | 6 | C | LANSOPROL | 2 | Oral | 30 MG, QD | 0 | 30 | MG | QD | ||||||||
| 126474271 | 12647427 | 7 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 126474271 | 12647427 | 8 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 342.857 MG, 3/WEEK | 0 | 342.857 | MG | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126474271 | 12647427 | 1 | Plasma cell myeloma |
| 126474271 | 12647427 | 3 | Plasma cell myeloma |
| 126474271 | 12647427 | 4 | Plasma cell myeloma |
| 126474271 | 12647427 | 6 | Product used for unknown indication |
| 126474271 | 12647427 | 7 | Product used for unknown indication |
| 126474271 | 12647427 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126474271 | 12647427 | LT |
| 126474271 | 12647427 | HO |
| 126474271 | 12647427 | DE |
| 126474271 | 12647427 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126474271 | 12647427 | Acute kidney injury | |
| 126474271 | 12647427 | Diarrhoea | |
| 126474271 | 12647427 | Escherichia sepsis | |
| 126474271 | 12647427 | Hypotension | |
| 126474271 | 12647427 | Hypoxia | |
| 126474271 | 12647427 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126474271 | 12647427 | 7 | 20160704 | 20160718 | 0 | |
| 126474271 | 12647427 | 8 | 20160704 | 20160718 | 0 |